Goldman Sachs Group Inc Lannett CO Inc Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.47 - $0.87 $20,401 - $37,764	43,408 New	43,408 $25,000
Q2 2022 Aug 15, 2022	BUY	$0.47 - $0.87 $9,563 - $17,702	20,348 Added 88.24%	43,408 $25,000
Q1 2022 May 16, 2022	SELL	$0.75 - $1.77 $11,248 - $26,546	-14,998 Reduced 39.41%	23,060 $18,000
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $36,861 - $69,232	23,629 Added 163.76%	38,058 $62,000
Q3 2021 Nov 10, 2021	BUY	$2.91 - $4.83 $41,988 - $69,692	14,429 New	14,429 $43,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.